From api.bing.com
()
“Prostaglandin analogs are often used as a first line of treatment to lower intraocular pressure in patients with open-angle glaucoma. The approval of ZIOPTAN will provide a new, effective option to lower IOP,” said George L. Spaeth, M.D., Wills Eye ...
- FDA approves Mobius Therapeutics’ glaucoma surgery drug (bizjournals.com)
- U.S. FDA approves new skin cancer medicine (feedproxy.google.com)
- FDA Approves Genzyme's Framingham Plant (api.bing.com)
On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge. Basal cell carcinoma is a slow growing, painless cancer that starts in the...
From medicalnewstoday.com
()
- FDA approves drug to treat common form of skin cancer (api.bing.com)
Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice® (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion ...
From api.bing.com
()
- FDA Approves a 10-Minute, No-Comb Treatment for Head Lice (api.bing.com)
- FDA Approves No-Comb Treatment for Head Lice (api.bing.com)
... and Drug Administration has approved the stimulant medication lisdexamfetamine dimesylate (Vyvanse, Shire) as maintenance therapy for adults with attention deficit hyperactivity disorder (ADHD). According to a press release issued by the ...
From api.bing.com
()
- FDA approves no-comb head lice treatment (api.bing.com)
- FDA approves Baxter's TISSEEL for general hemostasis in surgery (news-medical.net)
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved INLYTA (axitinib), a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy. The approval is based on data from the Phase 3 AXIS trial, which demonstrated that INLYTA significantly extended progression free...
From rss.biospace.com
()
- FDA approves Pfizer’s Inlyta, kidney cancer drug (api.bing.com)
RIDGEFIELD, Conn., and INDIANAPOLIS, Jan. 30, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto™ (linagliptin/metformin hydrochloride) tablets, a...
From rss.prnewswire.com
()
- FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and... (rss.biospace.com)
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET® XR (sitagliptin and metformin hydrochloride (HCl) extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of JANUVIA® (sitagliptin), with extended-release metformin. JANUMET XR provides a...
From businesswire.com
()
- BRIEF-FDA approves Janumet XR for type 2 diabetes (api.bing.com)
Overview
This portal will discuss the relasionship between the FDA and Big Pharmaceutical companies and how it affects the health of American citizens.
